IDStewardship
JUNE 12, 2022
In this post an infectious diseases pharmacist identifies and discusses 5 things learned from #ASMicrobe 2022 – through Twitter. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 13 June 2022. There are many scientific meetings to go to these days. For infectious diseases enthusiasts, just a few that come to mind include IDweek, ECCMID, ASMicrobe, ACCP, and MAD-ID.
PharmExec
JUNE 13, 2022
While the pharmaceutical industry has historically lagged behind other industries in the overall shift to programmatic advertising, the pandemic accelerated this transformation to emerging channels like connected TV (CTV).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 16, 2022
The litany of failed trials of amyloid-targeting drugs for Alzheimer’s disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline in patients with an inherited form of the disease. The result isn’t a big surprise – Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s in early 2019 after interim analyses found it would be futile to continue – but is another blow to the
Outsourcing Pharma
JUNE 14, 2022
During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
JUNE 16, 2022
An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.
PharmExec
JUNE 13, 2022
Makar discusses the significance of AstraZeneca’s diabetes and heart failure drug Forxiga (dapagliflozin) for the treatment of chronic kidney disease (CKD).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
JUNE 14, 2022
The company has completed its early-phase development and manufacturing facility in Bend, giving it 11 processing suites focused on first steps into the clinic.
PharmaVoice
JUNE 15, 2022
Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.
PharmExec
JUNE 17, 2022
We may be only at the beginning of outcome-measured, value-based healthcare, but this is a chance for pharma organizations to show their mettle as roles are redefined and definitions of ‘value’ are agreed, says Gérard Klop of Vintura.
pharmaphorum
JUNE 17, 2022
It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing who are also at high risk for progression to severe COVID-19.” . At the time of authorisation, the United States federal government had already purchased 10 million doses of the drug.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Aureus Medical Group
JUNE 17, 2022
One of the exciting perks of travel nursing is the ability to visit amazing cities, parks, and monuments across the country. To help you celebrate Pride this year, we’ve assembled a handful of historic Pride landmarks and memorials across the U.S. that you can visit all year-long. So plan a road trip, a weekend getaway, or hop across town to discover, reflect, and celebrate the history that’s shaped the LGBTQIA+ community.
OctariusRx
JUNE 17, 2022
This weekend we celebrate Father’s Day. From the OctariusRx team to all our clients, vendors, friends and family, we wish all fathers and father figures a Happy Father’s Day! Fathers are the first teachers and also our toughest critics. Fathers always inspire us to do better. Hard work has always been hereditary in our house. Thank you, Dad, for showing me that all dreams are within reach when you work hard enough to achieve them.
PharmExec
JUNE 16, 2022
Recent increases in employee burnout and turnover must be addressed.
pharmaphorum
JUNE 16, 2022
When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range of data-led metrics about each DOL to fine tune the engagement and maximise benefit for all parties. The simplest, and often easiest metrics to obtain, relate to the activity characteristics of the Digital KOL. In Twitter for example, this may equate to the DOL’s activity levels, follower numbers, and so on.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Aureus Medical Group
JUNE 17, 2022
June 19th has been a day of remembrance and reflection for over 155 years, and in 2021 was officially declared a federal holiday. Juneteenth celebrates the day enslaved Americans first learned that slavery ended, two years after the Emancipation Proclamation was declared in 1863. Communities, schools, and businesses across the country come together to listen, learn, and spread awareness of the past and present issues facing the Black community.
Board Vitals - Pharmacist
JUNE 15, 2022
Physicians aren’t alone in their continuing education requirements. Nursing continuing education is required in most states to ensure that nurses and nurse practitioners keep their knowledge up to date. What do you need to know about CME for nurses, and how can you fulfill your requirements? . Why Do Nurses Need to Earn Continuing Education? . As the medical industry advances, so must the knowledge nurses have.
PharmExec
JUNE 14, 2022
Industry must continue research and development to combat the pandemic.
pharmaphorum
JUNE 15, 2022
The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. The industry is uniting to address mechanisms of drug resistance, spearhead progress in molecular subtyping and define practice-changing drug sequencing and combinations for the largest solid tumor indication, NSCLC.
NICE
JUNE 15, 2022
By Jeanette Kusel, director of scientific advice, Mark Salmon, programme director of information resrouces and Sarah Byron, interim programme director for devices, diagnostics and digital at NICE. The explosion in digital health products has left NHS commissioners wondering how they can possibly sift out what works and what provides maximum benefit for the service and for patients.
Digital Pharmacist
JUNE 15, 2022
Men’s health week is upon us and we are thrilled to be raising awareness with you. The goal of this week is to focus on encouraging boys, men, and their families to practice and implement healthy living decisions, such as exercising and eating plenty of fruits and vegetables. Focusing on men’s health and raising awareness is imperative as we strive to keep our communities healthy.
PharmExec
JUNE 17, 2022
Measure tackles infant formula, cosmetics, and diagnostics—plus drug development and access.
pharmaphorum
JUNE 16, 2022
In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials. They discuss the nitty-gritty of clinical trial diversity – why it’s been so hard to achieve, why it’s important, and how to overcome the specific barriers to inclusion for different underrepresented communities.
NICE
JUNE 15, 2022
I’ve seen many changes to the health and care landscape since I’ve been at NICE – some more significant than others. But I feel that the point we’re at now is particularly striking. New, innovative, and potentially disruptive treatments are being developed at a pace we haven’t seen before – leading to medicines of great range and complexity.
Viseven
JUNE 14, 2022
Once there’s an inquiry about how to improve pharmaceutical sales representatives’ performance, there’s a need to ask a simple question: “What does it mean to be a pharmaceutical representative? What is exactly a pharma rep’s responsibility zone?” Looking for the answer, you may find that the key role of a pharma representative is to deliver the pharma company’s ideas and messages to the health care reps in a most efficient, understandable, and intelligi
PharmExec
JUNE 14, 2022
Wednesday June 15, 2022 from 11am EDT | 8am PDT| 4pm BST | 5pm CEST IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients.
pharmaphorum
JUNE 16, 2022
MorphoSys seemingly inexorable shift into an oncology pure-play has continued with an out-licensing deal for two programmes in the kidney disease and immunology categories to China’s HIBio. The German biotech is handing over rights to CD38-targeted antibody felzartamab for two forms of glomerulonephritis and MOR210, an anti-C5aR1 antibody for autoimmune disorders and some forms of cancer, which are both currently in early-stage clinical testing.
NICE
JUNE 15, 2022
Innovative medicines, medical devices and diagnostics are arriving at an unprecedented pace. At NICE, it’s our duty to keep ahead of these developments to make sure patients gain rapid access to the most promising, cutting-edge treatments. So, we’re taking a number of measures to address this. These include developing a proportionate approach to technology appraisals to increase our capacity.
PharmD Live
JUNE 13, 2022
By Ryan Payne, PharmD. Because of the insidious nature of chronic kidney disease, and because most people affected do not have symptoms until the condition becomes advanced, it is sometimes under-recognized by busy healthcare providers. According to the National Kidney Foundation, kidney disease affects an estimated 37 million people in the United States.
PharmExec
JUNE 13, 2022
Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
pharmaphorum
JUNE 14, 2022
Eli Lilly and Incyte’s Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 people in the US. The JAK1/2 inhibitor has been cleared for adults who are severely affected with the condition at a dose of 2mg once-daily, which can be stepped up to 4mg/day if needed, and according to the FDA will “help fulfil a significant unmet need for patients.” It is estimated tha
Outsourcing Pharma
JUNE 16, 2022
This monthâs announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.
Pharma Manufacturing
JUNE 17, 2022
The digitalization journey for pharmaceutical manufacturing can reap many benefits and there are many choices to be made in terms of these technologies and how to deploy them. In this episode, Andrea Corona talks about how digitalization is delivering a competitive advantage and assembly and inspection with Veronica Ghidotti and.
PharmExec
JUNE 13, 2022
Eagle tele-rheumatology joins list of more than 15 physician specialties.
pharmaphorum
JUNE 16, 2022
A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from a newly-announced partnership between digital health specialist Sidekick and pharma group Eli Lilly. The two companies say the integrated digital therapeutic (DTx) for breast cancer will aim to promote behaviour modifications to improve the wellbeing of breast cancer patients as well as adherence to drug treatment, foe example by managing side effects.
Expert insights. Personalized for you.
130 
Let's personalize your content